SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India submits board meeting intimation

20 Jul 2026 Evaluate
Sanofi India has informed that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of Sanofi India is scheduled to be held on Tuesday, 4th August 2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th June 2026. Further, in reference to intimation dated 26th June 2026 for closure of trading window, they informed that the trading window for the purpose of publication of Unaudited Financial Results of the Company for the quarter and half year ended 30th June 2026 shall remain closed from Wednesday, 1st July 2026 till to Thursday, 6th August 2026.

The above information is a part of company's filings submitted to BSE. 

Sanofi India Share Price

3393.80 0.00 (0.00%)
20-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1956.30
Dr. Reddys Labs. 1223.30
Cipla 1441.45
Lupin 2478.30
Zydus Lifesciences 1146.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: